News
CNTN
2.260
-3.42%
-0.080
Weekly Report: what happened at CNTN last week (0928-1002)?
Weekly Report · 2d ago
Weekly Report: what happened at CNTN last week (0921-0925)?
Weekly Report · 09/28 09:12
Weekly Report: what happened at CNTN last week (0914-0918)?
Weekly Report · 09/21 09:12
Weekly Report: what happened at CNTN last week (0907-0911)?
Weekly Report · 09/14 09:12
Weekly Report: what happened at CNTN last week (0831-0904)?
Weekly Report · 09/07 09:12
Weekly Report: what happened at CNTN last week (0824-0828)?
Weekly Report · 08/31 09:13
Weekly Report: what happened at CNTN last week (0817-0821)?
Weekly Report · 08/24 09:13
Weekly Report: what happened at CNTN last week (0810-0814)?
Weekly Report · 08/17 09:13
Canton Strategic Holdings, Inc. GAAP EPS of -$0.08, revenue of $1.5M
Seeking Alpha · 08/14 14:07
Canton Strategic Holdings, Inc. - Common Stock Q2 EPS $(0.08) Up From $(0.50) YoY, Sales $1.496M
Benzinga · 08/14 13:11
*Canton Strategic Holdings 2Q Cont Ops Loss/Shr 8c >CNTN
Dow Jones · 08/14 13:06
*Canton Strategic Holdings 2Q Rev $1.5M >CNTN
Dow Jones · 08/14 13:05
Press Release: Canton Strategic Holdings, Inc. -2-
Dow Jones · 08/14 13:00
Press Release: Canton Strategic Holdings, Inc. Releases Second Quarter 2026 Financial and Operational Results
Dow Jones · 08/14 13:00
Weekly Report: what happened at CNTN last week (0803-0807)?
Weekly Report · 08/10 09:12
Canton Strategic: Highly Intriguing Blockchain Treasury With Tangible Risks
Seeking Alpha · 08/06 16:46
Weekly Report: what happened at CNTN last week (0727-0731)?
Weekly Report · 08/03 09:12
*Canton Strategic Holdings Names Sean Galvin, Pamela Carter, Rishi Nangalia to Board
Dow Jones · 07/28 12:15
Press Release: Three New Directors Elected to the Board of Canton Strategic Holdings, Inc.
Dow Jones · 07/28 12:15
Weekly Report: what happened at CNTN last week (0720-0724)?
Weekly Report · 07/27 09:13
More
Webull provides a variety of real-time CNTN stock news. You can receive the latest news about Canton Strategic Holdings through multiple platforms. This information may help you make smarter investment decisions.
About CNTN
Canton Strategic Holdings, Inc., formerly Tharimmune, Inc., is advancing institutional blockchain adoption to drive the digitization of financial markets. In addition to driving value through activities on the Canton Network, the Company operates a Super Validator, ensuring safe and secure transactions across the Network. The Company also operates a clinical-stage biotech research and development arm. Its lead clinical asset, GV104, is being developed for a specific indication via a 505(b)2 pathway for respiratory and/or nervous system depression in military personnel and chemical incident responders who may encounter high-potency opioids. The expanded pipeline includes other indications for GV104 and GV023, a new approach to autoimmune diseases, as well as an early-stage multispecific biologic platform.